´
C. Perollier, M. Mazzanti, J.-P. Simonato, F. Launay, R. Ramasseul, J.-C. Marchon
FULL PAPER
free base porphyrin was obtained as a mixture with its zinc complex
(presumably due to inorganic additives on silica plates). In that
case the mixture was dissolved in CH2Cl2, washed with 0.2 HCl
7% yield. MS-FABϩ m/z: 1183 [MHϩ]. – UV/Vis (CH2Cl2) λmax
/
nm (log ε) ϭ 431 (5.47), 529 (4.11), 567 (3.64), 608 (3.59), 666
1
(2.95). H NMR (200 MHz, CDCl3) δ ϭ –1.45 (s, NH), 0.9 (s, 12
(3 ϫ 25 mL) and with a saturated aqueous NaHCO3 solution (3 ϫ H, CH3), 2.05 (s, 12 H, CH3), 2.95 [d, 4 H, J ϭ 8.8 Hz, CH-C(O)],
25 mL). After drying (Na2SO4) and solvent evaporation, the pure
porphyrin was obtained in 2–15% yield.
3.55 (s, 12 H, OCH3), 4.95 [d, 4 H, J ϭ 8.8 Hz, CH-CH-C(O)O],
6.45 (m, 16 H, Haro), 9.1 (s, 4 H, Hβ), 9.45 (s, 4 H, Hβ).
meso-Tetrakis[(1R,3S)-1-(m-nitrophenoxycarbonyl)-2,2-dimethyl-
cycloprop-3-yl]porphyrin (2h): Chiroporphyrin 2h was obtained in
14% yield. MS-FABϩ 1243 [MHϩ]. – UV/Vis (CH2Cl2) λmax/nm
(log ε) ϭ 428 (5.2), 537 (4), 565 (3.5), 605 (3.5), 665 (3.1). – 1H
NMR (200 MHz, CDCl3) δ ϭ –1.5 (s, NH), 0.88 (s, 12 H, CH3),
2.05 (s, 12 H, CH3), 3.05 (d, 4 H, J ϭ 8.8 Hz, CH-C(O)), 5.16 (d,
4 H, J ϭ 8.8 Hz, CH-CH-C(O)O), 6.64 (ddd, 4 H, CHaro, J ϭ 8.17,
J ϭ 2 and J ϭ 1 Hz), 7.06 (dd, 4 H, CHaro, J ϭ 8.2, 2 and 1 Hz),
7.5 (dd, 4 H, CHaro, J ϭ 8.2 and 2 Hz), 7.73 (ddd, 4 H, CHaro, J ϭ
8.1, 2 and 1 Hz), 9.13 and 9.60 (2s, 8 H, Hβ).
meso-Tetrakis[(1R,3S)-1-ethoxycarbonyl-2,2-dimethylcycloprop-3-
yl]porphyrin (2b): Chiroporphyrin 2b was obtained in 2% yield. –
UV/Visible (CH2Cl2) λmax/nm ϭ 428, 528, 565, 605, 663. – 1H
NMR (300 MHz, CDCl3): δ ϭ –1.6 (s, NH), 0.75 (t, 12 H, J ϭ
7.05 Hz), 0.82 (s, 12 H, CH3), 1.92 (s, 12 H, CH3), 2.71 [d, 4 H,
J ϭ 8.8 Hz, CH-C(O)], 3.55 (m, 8 H, OCH2), 4.78 [d, 4 H, J ϭ
8.8 Hz, CH-CH-C(O)O], 9.07 (1s, 4 H, Hβ1), 9.19 (s, 4 H, Hβ2). –
13C NMR (50 MHz, CDCl3): δ ϭ 13.7 (CH3), 18.1 (CH3), 27.5
(CIV), 29.2 (CH3), 33.2 (CH), 37.9 (CH), 59.5 (OCH2), 110.0
(Cmeso), 127.6 (Cβ pyr.), 130.9 (Cβ), 145.8 (Cα pyr.), 153.7 (Cα),
170.3 (CϭO).
meso-Tetrakis[(1R,3S)-1-(p-nitrophenoxycarbonyl)-2,2-dimethyl-
cycloprop-3-yl]porphyrin (2i): Chiroporphyrin 2i was obtained in
5.5% yield. Crystallization of the pure product was induced by slow
addition of n-hexane to a concentrated dichloromethane solution
of the crude product. UV/Vis (CH2Cl2) λmax /nm (log ε) ϭ 431
meso-Tetrakis[(1R,3S)-1-tert-butoxycarbonyl-2,2-dimethylcyclo-
prop-3-yl]porphyrin (2c): Chiroporphyrin 2c was obtained in 5%
yield. MS-FABϩ m/z: 983.2 [MHϩ]. – UV/Vis (CH2Cl2) λmax/nm
1
428, 528, 565, 605, 662. – H NMR: δ ϭ –1.58 (s, NH), 0.44 (s, 36
1
(5.5), 536 (4), 565 (3.6), 605 (3.6), 670 (3). – H NMR (200 MHz,
H, tBu), 0.83 (s, 12 H, CH3), 1.92 (s, 12 H, CH3), 2.61 [d, 4 H, J ϭ
8.8 Hz, CH-C(O)], 4.72 [d, 4 H, J ϭ 8.8 Hz, CH-CH-C(O)O], 9.06
(1s, 4 H, Hβ1), 9.27 (s, 4 H, Hβ2). – 13C NMR 50 MHz, CDCl3, δ
18.4 (CH3), 27.2 (CH3 tBu), 29.4 (CH3), 30.7 (CIV tBu) 34.7 (CH),
37.7 (CH), 79.4 (CIV tBuO), 110.4 (Cmeso), 127.5 (Cβ pyr.), 131.1
(Cβ), 142.9 (Cα pyr.), 149.2 (Cα), 169.8 (CϭO).
CDCl3) δ ϭ –1.41 (s, NH), 0.88 (s, 12 H, CH3), 2.05 (s, 12 H, CH3),
3.0 [d, 4 H, J ϭ 8.8 Hz, CH-C(O)], 5.05 [d, 4 H, J ϭ 8.8 Hz, CH-
CH-C(O)O], 6.51 (d, 8 H, J ϭ 8.6 Hz, CHaro), 7.77 (d, 8 H, J ϭ
8.6 Hz, CHaro), 9.14 and 9.38 (2s, 8 H, Hβ).
meso-Tetrakis[(1R,3S)-1(N-methyl-N-phenyl)carbamoyl-2,2-dimeth-
ylcycloprop-3-yl]porphyrin (2j): Chiroporphyrin 2j was obtained in
meso-Tetrakis[(1R,3S)-1-neopentoxycarbonyl-2,2-dimethyl-
cycloprop-3-yl]porphyrin (2d): Chiroporphyrin 2d was obtained in
1.5% yield. MS-FABϩ m/z: 1039.6 [MHϩ]. – UV/Vis (CH2Cl2)
λmax/nm (log ε) ϭ 428 (5.5), 536 (4), 565 (3.6), 605 (3.5), 660(3). –
1H NMR (200 MHz, CDCl3) δ ϭ –1.36 (s, NH), 0.32 (s, 36 H,
tBu), 0.77 (s, 12 H, CH3), 1.93 (s, 12 H, CH3), 2.75 [d, 4 H, J ϭ
8.8 Hz, CH-C(O)], 2.85 (d, 4 H, J ϭ 10.5 Hz, OCH), 3.18 (d, 4 H,
J 10.5 Hz, OCH), 4.83 [d, 4 H, J ϭ 8.8 Hz, CH-CH-C(O)O], 9.06
and 9.15 (2s, 8 H, Hβ).
7% yield. MS-FABϩ m/z: 1114 [M•ϩ] [exact mass of MHϩ
ϭ
1115.5868 (∆ ϭ 3.8 ppm); exact mass of M•ϩ ϭ 1114.5602 (∆ ϭ
21 ppm)]. – UV/Vis (CH2Cl2) λmax/nm ϭ 432, 532, 563, 609, 663. –
1H NMR (400 MHz, CDCl3) δ ϭ –1.29 (br. s, 2 H, NH), 0.95 (s,
12 H, CH3), 1.74 (s, 12 H, CH3), 2.53 [d, J ϭ 8.2 Hz, 4 H, CH-
C(O)N], 2.88 (s, 12 H, N-CH3), 4.58 [d, J ϭ 8.2 Hz, 4 H, CH-CH-
C(O)N], 7.42–7.66 (m, 20 H, CHaro), 9.01 and 9.13 (2s, 8 H, Hβ). –
13C NMR (100 MHz, CD2Cl2) δ ϭ 18.0 (Me), 27.6 (CIV), 28.6
(CH3), 32.5 (CH), 37.1 (CH), 38.0 (N-CH3), 111.3 (CIV meso),
127.4 (CHaro), 128.0 (CHaro), 128.2 (Cβ), 130.0 (CHaro), 130.5
(Cβ), 145.6 (CIV aro), 146.3 (b, Cα), 169.3 (CϭO).
meso-Tetrakis[(1R,3S)-1-(1(S)-endo-bornoxy)carbonyl-2,2-dimeth-
ylcycloprop-3-yl]porphyrin (2e): Chiroporphyrin 2e was obtained in
5% yield. MS-FABϩ m/z: 1303.8 [MHϩ]. – UV/Vis (CH2Cl2) λmax
/
meso-Tetrakis[(1R,3S)-1(N-ethyl-N-phenyl)carbamoyl-2,2-di-
methylcycloprop-3-yl]porphyrin (2k): Chiroporphyrin 2k was pre-
pared in 6% yield using the ‘‘typical procedure’’. By adding Et3N
(1 equiv.) after reaction with DDQ, the yield rose to 12%. MS-
FABϩ m/z: 1171.7 [MHϩ]. – UV/Vis (CH2Cl2) λmax/nm ϭ 434, 533,
nm (log ε) ϭ 376 (4.1), 430 (5.4), 530 (4), 567 (3.6), 605 (3.6), 664
1
(3). – H NMR (200 MHz, CDCl3) δ ϭ –1.27 (s, NH), –0.45 (s, 12
H, bornyl CH3 ), 0.41 (s, 12 H, bornyl CH3), 0.42 (s, 12 H, bornyl
CH3), 0.77 (s, 12 H, CH3), 1.92 (m, bornyl H), 1.92 (s, 12 H, CH3),
2.71 [d, 4 H, J ϭ 8.8 Hz, CH-C(O)], 4.10 (m, 4 H, bornyl OCH),
4.78 [d, 4 H, J ϭ 8.8 Hz, CH-CH-C(O)O], 9.03 and 9.17 (2s, 8
H, Hβ).
1
564, 610, 633. – H NMR (400 MHz, CDCl3) δ ϭ –1.21 (b, 2 H,
NH), 0.80 (t, J ϭ 6.8 Hz, 12 H, CH3), 0.90 (s, 12 H, CH3), 1.72 (s,
12 H, CH3), 2.38 [d, J ϭ 8.3 Hz, 4 H, CH-C(O)N], 3.37 (m, 8 H,
N-CH2), 4.56 [d, J ϭ 8.3 Hz, 4 H, CH-CH-C(O)N], 7.42–7.65 (m,
20 H, CHaro), 9.01 and 9.15 (2s, 8 H, Hβ). – 13C NMR (100 MHz,
CD2Cl2) δ 12.7 (Me), 17.4 (Me), 26.8 (CIV), 27.9 (CH3), 32.2 (CH),
37.2 (CH), 43.2 (N-CH2), 110.7 (CIV meso), 126.9 (CHaro), 127.5
(Cβ), 128.4 (CHaro), 129.2 (CHaro), 130.0 (Cβ), 143.4 (CIV aro),
144.4 (Cα), 146.1 (Cα), 168.0 (CϭO, CIV).
meso-Tetrakis[(1R,3S)-1-benzyloxycarbonyl-2,2-dimethylcycloprop-
3-yl]porphyrin (2f): Chiroporphyrin 2f was obtained in 2% yield. –
1
UV/Vis (CH2Cl2) λmax/nm ϭ 428, 528, 565, 605, 663. – H NMR
(300 MHz, CDCl3) δ ϭ –1.51 (s, NH), 0.87 (s, 12 H, CH3), 1.97 (s,
12 H, CH3), 2.86 [d, 4 H, J ϭ 8.9 Hz, CH-C(O)O], 4.38 (d, 4 H,
J ϭ 12.2 Hz, benzylic OCH), 4.48 (d, 4 H, J ϭ 12.2 Hz, OCH),
4.86 [d, 4 H, J ϭ 8.8 Hz, CH-CH-C(O)O], 6.30 (d, 8 H, CHaro-o
,
(1R,3S)-N-(N’-cyclohexyl)carbamoyl-N-cyclohexyl-3-formyl-2,2-di-
methylcyclopropane-1-carboxamide (1l): (1R)-cis-hemicaronal-
dehydic acid (7.1 g, 50 mmol), Et3N (8.4 mL, 1.2 equiv.), and DCC
(12.4 g, 60 mmol, 1.2 equiv.) were mixed and stirred in DMF
(100 mL) for 12 hours. After addition of CH2Cl2 (25 mL), the reac-
tion mixture was washed successively with an aqueous HCl (10%)
solution (3 ϫ 25 mL), with a saturated aqueous NaHCO3 solution
(3 ϫ 25 mL) and with water (8 ϫ 25 mL). The organic layer was
dried with Na2SO4 and the solvent was removed in vacuo. The
J ϭ 7.6 Hz), 6.47 (t, 8 H, CHaro-m, J ϭ 7.6 Hz), 6.85 (t, 4 H, CHaro-p
,
J ϭ 7.3 Hz), 9.11(s, 4 H, Hβ), 9.18 (s, 4 H, Hβ). – 13C NMR
75 MHz, CDCl3 δ 18.2 (CH3), 28.1 (CIV), 29.2 (CH3), 33.6 (CH),
38.4 (CH), 66.0 (OCH2), 110.7 (Cmeso), 127.9 (CHaro), 128.0
IV
(CHaro), 128.1 (CHaro et Cβ), 131.3 (Cβ), 136.0 (C ), 144.7 (Cα),
aro
147.8 (Cα), 170.6 (CϭO).
meso-Tetrakis[(1R,3S)-1-(p-methoxyphenoxycarbonyl)-2,2-dimeth-
ylcycloprop-3-yl]porphyrin (2g): Chiroporphyrin 2g was prepared in
588
Eur. J. Org. Chem. 2000, 583Ϫ589